BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, June 30, 2024
Breaking News: Try BioWorld for free for two weeks
See today's BioWorld Science
Home
» Blimp-1 ablation enhances antitumoral efficacy of ARI-0002-h CAR T cells
To read the full story,
subscribe
or
sign in
.
Immuno-oncology
Blimp-1 ablation enhances antitumoral efficacy of ARI-0002-h CAR T cells
June 26, 2024
No Comments
CAR T-cell therapy that targets BCMA is an effective option for treating relapsed/refractory multiple myeloma, but there is a lack of persistence due to the inability to develop a memory phenotype.
BioWorld Science
Conferences
CAR T
European Hematology Association
Cancer
Immuno-oncology